Hartley and Rowel reported that the in vitro focus-forming effects of Moloney sarcoma virus (MSV)2 I depended on the presence in the same cells of two virus particles, a defective i\ISV particle and a fully infectious Moloney leukemia particle. Superinfection with additional Moloney leukemia virus potentiated focus formation by MSV, converting a "two-hit" dose response curve to a one-hit curve; preliminary experiments also suggested a two-hit requirement for sarcoma induction in vivo by MISV. 4 These experiments suggested that murine leukemia viruses serve as "helpers" for a defective MSV particle in much the same way that avian leukosis viruses help to complete defective Rous sarcoma virus (RSV) infectious particles, but with the difference that in the \A1SV system in mouse cells helper virus may be required for cellular alteration as well. ' Sarma, Vass, and Huebner5 described a virus-free sarcoma induced in hamsters by the defective Bryan strain of RSV, the cells from which when propagated in mixed tissue cultures with chicken embryo fibroblasts transferred the noninfectious RSV genome to the latter. When the mixed cultures were superinfected with avian leukosis viruses, fully infectious RSV was released. On the other hand, when uninfected, mixed cultures were implanted in the wing web of leukosis-free chicks, virus-free sarcomas having the avian karyotype were produced. When cells from these sarcomas were grown in tissue cultures, they behaved as typical nonproducer (NP) sarcoma cells. The addition of avian leukosis viruses to these avian cells yielded infectious RSV. In this system, the "nonproducer" hamster and chick cells contain large amounts of complement-fixing (CF) and immunofluorescentstainable antigens believed to represent the internal protein moiety of the virus,6' 7 but the genetic information for the outer envelope must be supplied by the helper virus.
In this communication we describe fibrosarcomas induced in hamsters by the 1\Ioloney sarcoma virus which carry the defective AISV genome but not infectious MSV or murine leukemia virus nor mouse leukemia group reactive CF antigen. Falcon Plastics) were seeded with 4 X 104 HT-1 cells and 2 X 105 MEF cells in 4 ml and were infected either at the time of plating or 24 hr later, using 0.4 ml of virus dilution. In early experiments, medium for growth and maintenance was 10% heated calf serum in EMEM; more satisfactory results were later obtained with 10% unheated fetal bovine serum in EMEM, and this medium was used routinely thereafter. Fluids were harvested and replaced with fresh medium at intervals of 2-4 days. Since the HT-1 cells tended to outgrow the MEF cells, it was necessary to add fresh MEF cells to maintain a susceptible cell population for the leukemia viruses; 2 X 105 cells were added per plate, usually between the tenth to thirteenth day. Culture fluids were assayed for focus-inducing virus at various intervals.
Serology: Tests for the presence of the mouse leukemia group reactive CF antigen1' 9-11 in hamster and mouse tumor extracts were done with serum of a Fischer rat carrying a transplanted MSV-induced sarcoma; this serum reacted in both CF and neutralization tests with all mouse leukemia strains tested, but tended to have highest CF titers against MSV and Moloney virus antigens. Confirmatory CF tests, and focus neutralization tests, were done with sera of rats immunized with mouse leukemia viruses grown in tissue culture.
Animals: All animals were obtained from the NIH animal production colony.
Results.-Induction of MSV tumors in hamsters: Subcutaneous injection of the I\ISV inoculum (0.1 ml of a 10-1 dilution) in two sites produced local sarcomas in newborn hamsters which had gross and microscopic characteristics similar to the spindle cell sarcomas induced in BALB/c mice.'2 Although the same inoculum induced tumors in 12 of 12 newborn BALB/c mice within 10 days, the tumors induced with this dosage in hamsters were much delayed. In 22 newborn hamsters the first tumor was noted at 64 days and the second at 68 days. Subsequent tumors were noted at 170, 196, and 254 days, by which time 9 of the 22 hamsters had developed tumors. When the test was repeated with the same inoculuim, 7 tumors were observed by 200 days in 24 hamsters.
Subcutaneous transplantation of minced primary tumor tissue required 70 days or more to produce detectable tumors in newborn hamsters and 100 days in weanlings. However, in both weanlings and newborns, transplanted tumors grew progressively to large size; they often exceeded 50 mm in diameter and showed no tendency to regress. In contrast to the first transplant passage, second, third, and fourth transplant passages in newborn hamsters often yielded tumors in about half the hamsters in 10 days: however, this response was variable since other groups of hamsters receiving similar transplants sometimes required 30-60 days or more for successful tumor induction. A fifth transplant passage required over 130 days before tumors appeared in three of ten newborn hamsters.
Failure to detect virus or antigen in hamster tumor cells: A variety of techniques were employed in unsuccessful attempts to demonstrate leukemia or sarcoma virus in the hamster tumors and the HT-1 tissue culture cell line. Extracts of primary and transplanted tumors did not induce sarcomata when inoculated into newborn BALB/c, C57BL, and NIH strains of mice or into newborn hamsters; they did not induce foci in AIEF cultures when tested with or without Moloney leukemia virus as helper; they did not induce CF antigen in M\IEF; and they did not react in the CF test with broadly reactive sera of rats immunized with Moloney leukemia virus or the sarcoma virus. Also, hamsters carrying transplants of the tumor never developed CF antibody reactive with mouse leukemia virus antigens or the homologous tumor.
The HT-1 cells were similarly negative. Culture fluids and cell extracts were negative for CF antigen and did not induce foci or CF antigen in mouse embryo cultures. In a preliminary study, electron microscopic examination of thin sections of the cells revealed no particles suggestive of viruses.
Recovery of MSV genome by mixed culture with helper virus: When the hamster tumor cells were growii with NIH mouse embryo cells and the mixed culture inoculated with Moloney leukemia virus, focus-forming MSV was recovered regularly. The in vivo rescue of sarcomagenic virus was also successful with cells from two hamster tumor transplants other than those derived from the HT-1 cells.
Properties of the viruses recovered from the in vitro and in vivo rescue experiments: The fluids from the assay plates in the mixed culture experiments and the extracts of tumors developing in infant mice inoculated with HT-1 cells plus Moloney, Rauscher, or Friend virus readily induced foci when passed serially in MEF and CL-1 tissue cultures, and sarcomata when inoculated into infant mice. Table 2 shows some of the virologic characteristics of extracts of mouse tumors induced with viruses rescued in vitro or in vivo with these helpers. Like the standard MISV tumors, which generally contain CF antigen in titers of 1:8 to 1:16, the tumors induced by the rescued viruses reacted in CF with the MISV rat serum; the CF titers tended to be lower with the Rauscher and Friend rescued viruses, which may be a reflection of lower heterologous reactivity, often encountered with rat antisera to mouse leukemia viruses. The data in the table suggest a rough correlation between CF antigen titer and titer of focus-forming particles; all of those tested readily produced tumors in mice. In preliminary tests with rat antisera selected for having relatively type-specific neutralizing antibody, it appeared that the focus-forming viruses had acquired the serological character of the virus used for retrieval (Table 3) , in a manner analogous to that described for the Rous virus "pseudotypes."
Attempts to characterize the agents retrieved with Gross Passage A virus have been hampered by the low titers of focus-forming virus recovered in both the in vitro and in vivo systems.
Discussion.-The most likely explanation of the results reported here is the same as that proposed for the analogous finding with avian sarcoma virus-induced tumors of hamsters,5' [13] [14] [15] [16] [17] that is, that the defective genome of the sarcoma virus persists in the hamster cells, transfers to the mouse cells both in vitro and in vivo, and is propagated along with the superinfecting leukemia virus. It has been shown previously' that the focus-forming particles require helper virus for their replication in mouse cells. The inability of the leukemia virus to rescue the sarcoma genome directly from the hamster cells is probably due to failure of the leukemia viruses to propagate in hamster cells, though this has not been established beyond the observations that the cells do not form detectable levels of CF antigen following inoculation with various mouse leukemia viruses, and that antibodies to AISV virion preparations were not produced in the hamsters carrying MSV-induced tumors.
The Harvey strain of iAISV has been reported to induce tumors in hamsters,2 but Moloney's isolate has not previously been found to be oncogenic in this species."8 Whether the tumors induced by the Harvey strain are also noninfectious remains to be determined.
The failure to find the mouse leukemia group CF antigen in the 1\ISV hamster tumor cells represents a marked difference from the otherwise similar avian sarcoma virus-hamster tumor system,5-7 in which group reactive antigen19 is consistently present. This apparent discrepancy may be due to differences in the nature of the antigens. The mouse leukemia group antigen is inseparable from the virion4' 9 and probably represents an antigen in the envelope; the avian leukosis CF antigen in hamster cells is an internal virus protein6' 7 while envelope antigens, which are type-specific, are not detectable in the noninfectious tumor cells.
It is suggested that the term MSV be retained as the designation of the original sarcoma strains (Moloney's and Harvey's), and that the pseudotypes produced with the Moloney, Rauscher, Friend, or Gross Passage A leukemia viruses be designated MiSV(1\ILV), 1\ISV(RLV), M\SV(FLV), and I\ISV(GLV), respectively.
It will be important to determine whether or not the avian and murine models will provide useful patterns for studies of the etiology of sarcomas and leukemias of other species, including those observed in man.
Summary.-A hamster MSV-induced rhabdomyosarcoma carried in vivo and in vitro was free of infectious virus and CF antigen. When the hamster tumor cells were grown in contact with mouse cells, either as mixed tissue cultures or by inoculation into newborn mice, in the presence of various murine leukemia virus strains focus-forming and sarcomagenic viruses were readily recovered. Preliminary studies indicate that the focus-forming viruses so recovered have the envelope antigens of the helper virus, and thus represent newly created pseudotypes of MSV.
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